Log in to search using one of your social media accounts:

FDA Drug Safety Communication: Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy
The U.S. Food and Drug Administration (FDA) is updating the public about new actions being taken to address a known safety concern with codeine use in certain children after tonsillectomy and/or adenoidectomy (surgery to remove the tonsils and/or adenoids). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 25, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death
The U.S. Food and Drug Administration (FDA) is reviewing reports of children who developed serious adverse effects or died after taking codeine for pain relief after tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 25, 2017 Category: Drugs & Pharmacology Source Type: news

CT-P13, a Biosimilar of Anti-TNF-a for IBD CT-P13, a Biosimilar of Anti-TNF-a for IBD
Can CT-P13, a biosimilar of infliximab, be used safely in patients with inflammatory bowel diseases--and with comparable efficacy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 25, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Ebola outbreak rings alarm bells early
(Source: ScienceNOW)
Source: ScienceNOW - May 25, 2017 Category: Science Authors: Cohen, J. Tags: Epidemiology, Immunology, Pharmacology, Toxicology, Virology In Depth Source Type: news

Medical Device Alert: All HeartStart MRx defibrillators – possible failure to deliver a shock, cardioversion, pacing or monitoring
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alertfor all HeartStart MRx defibrillators (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

RPS warns against miracle weight loss "cures"
RPS England Board member Deborah Evans was interviewed by Talk Radio recently on the dangers of"miracle cures" for weight loss. Deborah exploded the myths around remedies that promise inst (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

RPS discusses diet pills on Talk Radio
RPS England Board member Deborah Evans was interviewed by Talk Radio recently on the dangers of miracle cures for weight loss. Deborah exploded the myths around remedies that promise instant results (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

Fluorouracil Injection (fluorouracil) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

Methadone (Methadone Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

Methadone (Methadone Tablets) - updated on RxList
Learn about Methadone (Dolophine) tablets side effects, may treat, uses, dosage, drug interactions, warnings, patient labeling, reviews, and related medications. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 24, 2017 Category: Drugs & Pharmacology Source Type: news

Duke joins concussion research funded by Microsoft co-founder's foundation
Duke University has joined a team led by the University of Pennsylvania along with Columbia University on new concussion research funded by a $9.25 million grant from The Paul G. Allen Family Foundation. Paul Allen co-founded Microsoft with Bill Gates. Researchers from Duke include Cameron R. “Dale” Bass, associate research professor of biomedical engineering, and Mohammed Abou Donia, professor of pharmacology and cancer biology and neurobiology, according to the university. “There is a surprising… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

BBC News reports on pharmacy and the General Election
Bolton pharmacist Thorrun Govind provided a pharmacy angle to the BBC’s coverage of the General Election on the 6pm news in an interview from a pharmacy in Lancashire. Thorrun explained the vit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 23, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Grants Priority Review to Merck ’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Recurrent or Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Dateline City: KENILWORTH, N.J. Data Supporting Application to Be Presented at 2017 ASCO Annual MeetingKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), the company ’s anti-PD-1 therapy, seeking approval for treatment of patients with recurrent or advanced gastric or gastroesophageal junction adenocarcinoma who have already received two or more lines of chemotherapy....
Source: Merck.com - Product News - May 23, 2017 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News #Merck #MRK $MRK cancer Keytruda MSD NYSE:MRK Source Type: news

Risk of HBV Reactivation in Patients on Antivirals for HCV Risk of HBV Reactivation in Patients on Antivirals for HCV
Is there a clinically relevant risk of HBV reactivation during direct-acting antiviral therapy for HCV with an interferon-free regimen?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature
May 23, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 23, 2017 Category: Drugs & Pharmacology Source Type: news

Disopyramide Phosphate (Norpace) Capsules (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis
PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara (sarilumab) for the treatment of adult patients with moderately to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs; review to continue
An FDA review to date has not identified adverse health effects from gadolinium retained in the brain after the use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). All GBCAs may be associated with some gadolinium retention in the brain and other body tissues. However, because we identified no evidence to date that gadolinium retention in the brain from any of the GBCAs, including GBCAs associated with higher retention of gadolinium, is harmful, restricting GBCA use is not warranted at this time. We will continue to assess the safety of GBCAs and plan to have a public meeting to discuss thi...
Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

La FDA actualiza las advertencias para los antibi ó ticos que contienen fluoroquinolonas que se inyectan o se toman por v í a oral debido a efectos secundarios discapacitantes
[07-26-2016] La Administraci ó n de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en ingl é s) aprob ó cambios a las etiquetas de medicamentos antibacterianos que contienen fluoroquinolonas para uso sist é mico (es decir, que se toman por v í a oral o se inyectan). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

La FDA actualiza las advertencias para los antibi óticos que contienen fluoroquinolonas que se inyectan o se toman por vía oral debido a efectos secundarios discapacitantes
[07-26-2016] La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) aprobó cambios a las etiquetas de medicamentos antibacterianos que contienen fluoroquinolonas para uso sistémico (es decir, que se toman por vía oral o se inyectan). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

hylan G-F 20 (Synvisc, Synvisc One)
Title: hylan G-F 20 (Synvisc, Synvisc One)Category: MedicationsCreated: 9/12/2001 12:00:00 AMLast Editorial Review: 5/22/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Adcirca (Tadalafil Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Arestin (Minocycline Hydrochloride Microspheres) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Lysodren (Mitotane) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Bumex (Bumetanide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Purixan (Mercaptopurine Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Saizen (Somatropin Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Forteo (Teriparatide (rDNA origin) Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Sabril (Vigabatrin Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Herceptin (Trastuzumab) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

New therapy for atherosclerosis developed by Ben-Gurion University
(American Associates, Ben-Gurion University of the Negev) 'Our E-selectin-targeting polymer reduces existing plaque and prevents further plaque progression and inflammation, preventing arterial thrombosis, ischemia, myocardial infarction, and stroke,' says Prof. Ayelet David of the BGU Department of Clinical Biochemistry and Pharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2017 Category: International Medicine & Public Health Source Type: news

FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis
May 22, 2017 -- The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS ® (raltegravir) 600 mg in the European Union
Dateline City: KENILWORTH, N.J.KENILWORTH, N.J.--(BUSINESS WIRE)--Merck  (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of ISENTRESS® (raltegravir) 600 mg film-coated tablets, in combination with other anti-retroviral medicinal products, for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.Language: EnglishContact: MerckMedia:P...
Source: Merck.com - Product News - May 19, 2017 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news

Medical Device Alert: All Lifepak 1000 automatic external defibrillators (AEDs) - risk of device shutting down unexpectedly during patient treatment and possible failure to deliver therapy
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for all Lifepak 1000 automatic external defibrillators manufactured by Physio Control. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

One week left to vote in the annual National Pharmacy Board elections
There is only one week left to vote in the annual National Pharmacy Board elections. The voting closes at 5pm, 26 May 2017. The board members you choose will play a key role in representing yo (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Grifulvin V (Griseofulvin Microsize) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Pred Mild (Prednisolone Acetate Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Minolira (Minocycline Hydrochloride Extended-Release Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Radicava (Brigatinib Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Glatopa (glatiramer acetate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Penicillin G Benzathine (Bicillin L-A) Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Potassium Phosphate Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Sodium Acetate Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Methotrexate Sodium Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Dextrose 50% Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Epinephrine Injection, 0.1 mg/mL (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

L-Cysteine Hydrochloride Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news

Labetalol Hydrochloride Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 18, 2017 Category: Drugs & Pharmacology Source Type: news